Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease

被引:2
|
作者
Li, Jie [1 ]
Liu, Yonghong [1 ]
Jin, Jian [1 ]
Shi, Qingfeng [1 ]
Ji, Yanting [1 ]
Zhang, Bo [1 ]
Hu, Pengfei [2 ]
机构
[1] Cangzhou Cent Hosp, Cangzhou 061000, Peoples R China
[2] Hebei Med Univ, Shijiazhuang 050017, Peoples R China
关键词
D O I
10.1155/2023/3133554
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective. To explore the clinicopathological features and risk factors of patients with multiple primary breast cancers and thyroid disease. Method. An analytic approach of the reviewing method was adopted to analyze the clinical data of 80 breast cancer patients who were admitted to our hospital from January 2020 to January 2022. They were divided into an observation group (breast cancer with thyroid lesions) and a control group (simple breast cancer) according to whether the clinical data were accompanied with thyroid lesions to compare the clinical characteristics, pathological types, staging characteristics, and molecular biological characteristics of the two groups and to research the risk factors of the two groups. Result. (1) In the comparison of clinical data, the number of people aged =60 in the observation group was higher than that in the control group, and there was significant difference between the groups in the menopausal status data (P<0.05). There was no statistical difference between the observation group and the control group in the comparison of clinical data of the body mass index, pregnancy frequency, labor frequency, and abortion history (P>0.05). (2) In the comparison of pathological type and staging data, there was no statistical difference in the comparison of data on the pathological type, histological grade, T staging, N staging, and TNM staging between the observation group and the control group (P>0.05). (3) In the comparison of data on molecular biology characteristics, there was a statistical difference in the nuclear proliferation antigen data between the observation group and the control group (P<0.05). There was no statistical difference in the comparison of data on the estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2, and molecular typing between the observation group and the control group (P>0.05). (4) Logistic regression analysis showed that age, menopausal status, and nuclear proliferation antigen index were the high-risk inflammatory factors for combined thyroid lesions (P<0.05). Conclusion. For patients with simple breast cancer, age, menopausal status, and nuclear proliferation antigen index are risk factors for combined thyroid lesions. Therefore, clinical attention should be paid to the above factors in the process of clinical treatment, and early-risk screening should be performed to achieve the purpose of improving the prognosis to the greatest extent.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Multiple primary cancers of the esophagus and thyroid gland
    Naomoto, Y
    Haisa, M
    Yamatsuji, T
    Shirakawa, Y
    Muramatsu, T
    Isozaki, H
    Kamikawa, Y
    Tanaka, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (07) : 349 - 352
  • [42] Clinicopathological Study of Triple Negative Breast Cancers
    Ishitha, Gunadala
    Manipadam, Marie Therese
    Backianathan, Selvamani
    Chacko, Raju Titus
    Abraham, Deepak Thomas
    Jacob, Paul Mazhuvanchary
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (09) : EC5 - EC9
  • [43] MULTIPLE PRIMARY CANCERS INVOLVING THE BREAST
    HORNROSS, PL
    EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) : 169 - 176
  • [44] MULTIPLE PRIMARY CANCERS OF THE BREAST AND OVARY
    PRIOR, P
    WATERHOUSE, JAH
    BRITISH JOURNAL OF CANCER, 1981, 44 (05) : 628 - 636
  • [45] Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24 553 patients with Hashimoto's disease
    Watanabe, Natsuko
    Noh, Jaeduk Y.
    Narimatsu, Hiroto
    Takeuchi, Kengo
    Yamaguchi, Takuhiro
    Kameyama, Kaori
    Kobayashi, Kazuhiko
    Kami, Masahiro
    Kubo, Atsushi
    Kunii, Yo
    Shimizu, Taeko
    Mukasa, Koji
    Otsuka, Fumiko
    Miyara, Ayako
    Minagawa, Akinobu
    Ito, Koichi
    Ito, Kunihiko
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (02) : 236 - 243
  • [46] Differences in Clinicopathological Features and Distribution of Risk Factors in Italian Melanoma Patients
    Fava, P.
    Astrua, C.
    Chiarugi, A.
    Crocetti, E.
    Pimpinelli, N.
    Fargnoli, M. C.
    Maurichi, A.
    Rubegni, P.
    Manganoni, A. M.
    Bottoni, U.
    Catricala, C.
    Cavicchini, S.
    Santinami, M.
    Alaibac, M.
    Annetta, A.
    Borghi, A.
    Pinton, P. Calzavara
    Capizzi, R.
    Clerico, R.
    Colombo, E.
    Corradin, M. T.
    De Simone, P.
    Fantini, F.
    Ferreli, C.
    Filosa, G.
    Girgenti, V.
    Giulioni, E.
    Guarneri, C.
    Lamberti, A.
    Lisi, P.
    Nardini, P.
    Papini, M.
    Peris, K.
    Pizzichetta, M. A.
    Salvini, C.
    Savoia, P.
    Strippoli, D.
    Tolomio, E.
    Tomassini, M. A.
    Vena, G. A.
    Zichichi, L.
    Patrizi, A.
    Argenziano, G.
    Simonacci, M.
    Quaglino, P.
    DERMATOLOGY, 2015, 230 (03) : 256 - 262
  • [47] Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database
    Shuting Li
    Jiao Yang
    Yanwei Shen
    Xiaoai Zhao
    Lingxiao Zhang
    Biyuan Wang
    Pan Li
    Yunmei Wang
    Min Yi
    Jin Yang
    BMC Public Health, 19
  • [48] Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database
    Li, Shuting
    Yang, Jiao
    Shen, Yanwei
    Zhao, Xiaoai
    Zhang, Lingxiao
    Wang, Biyuan
    Li, Pan
    Wang, Yunmei
    Yi, Min
    Yang, Jin
    BMC PUBLIC HEALTH, 2019, 19 (01)
  • [49] Germline PARP4 mutations in patients with primary thyroid and breast cancers
    Ikeda, Yuji
    Kiyotani, Kazuma
    Yew, Poh Yin
    Kato, Taigo
    Tamura, Kenji
    Yap, Kai Lee
    Mester, Jessica L.
    Nielsen, Sarah H.
    Raymon, Grogan H.
    Eng, Charis
    Nakamura, Yusuke
    CANCER RESEARCH, 2016, 76
  • [50] Germline PARP4 mutations in patients with primary thyroid and breast cancers
    Ikeda, Yuji
    Kiyotani, Kazuma
    Yew, Poh Yin
    Kato, Taigo
    Tamura, Kenji
    Yap, Kai Lee
    Nielsen, Sarah M.
    Mester, Jessica L.
    Eng, Charis
    Nakamura, Yusuke
    Grogan, Raymon H.
    ENDOCRINE-RELATED CANCER, 2016, 23 (03) : 171 - 179